Fatigue during treatment for hepatitis C virus: results of self-reported fatigue severity in two Phase IIb studies of simeprevir treatment in patients with hepatitis C virus genotype 1 infection

to related objects

Location
Deutsche Nationalbibliothek Frankfurt am Main
ISSN
1471-2334
Extent
Online-Ressource
Language
Englisch
Notes
online resource.

Bibliographic citation
Fatigue during treatment for hepatitis C virus: results of self-reported fatigue severity in two Phase IIb studies of simeprevir treatment in patients with hepatitis C virus genotype 1 infection ; volume:14 ; number:1 ; day:26 ; month:8 ; year:2014 ; pages:1-15 ; date:12.2014
BMC infectious diseases ; 14, Heft 1 (26.8.2014), 1-15, 12.2014

Creator
Scott, Jane
Contributor
Rosa, Kathleen
Fu, Min
Cerri, Karin
Peeters, Monika
Beumont, Maria
Zeuzem, Stefan
Evon, Donna M.
Gilles, Leen
SpringerLink (Online service)

DOI
10.1186/1471-2334-14-465
URN
urn:nbn:de:1111-2016030317960
Rights
Der Zugriff auf das Objekt ist unbeschränkt möglich.
Last update
15.08.2025, 7:38 AM CEST

Data provider

This object is provided by:
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Show original at data provider

Associated

  • Scott, Jane
  • Rosa, Kathleen
  • Fu, Min
  • Cerri, Karin
  • Peeters, Monika
  • Beumont, Maria
  • Zeuzem, Stefan
  • Evon, Donna M.
  • Gilles, Leen
  • SpringerLink (Online service)

Other Objects (12)

Overcoming the roadblocks in hepatitis C virus infection

Overcoming the roadblocks in hepatitis C virus infection

Fatigue during treatment for hepatitis C virus : results of self-reported fatigue severity in two Phase IIb studies of simeprevir treatment in patients with hepatitis C virus genotype 1 infection

Fatigue during treatment for hepatitis C virus : results of self-reported fatigue severity in two Phase IIb studies of simeprevir treatment in patients with hepatitis C virus genotype 1 infection

Concise review : interferon-free treatment of hepatitis C virus-associated cirrhosis and liver graft infection

Concise review : interferon-free treatment of hepatitis C virus-associated cirrhosis and liver graft infection

IL28B single nucleotide polymorphisms in the treatment of hepatitis C

IL28B single nucleotide polymorphisms in the treatment of hepatitis C

From non-A, non-B hepatitis to hepatitis C virus cure

From non-A, non-B hepatitis to hepatitis C virus cure

Hepatitis C im Dialog : 100 Fragen - 100 Antworten ; 11 Tabellen

Hepatitis C im Dialog : 100 Fragen - 100 Antworten ; 11 Tabellen

Telaprevir, peginterferon alfa-2a, and ribavirin for 28 days in chronic hepatitis C patients

Telaprevir, peginterferon alfa-2a, and ribavirin for 28 days in chronic hepatitis C patients

Emerging therapies for the treatment of hepatitis C

Emerging therapies for the treatment of hepatitis C

Therapie der chronischen Hepatitis C (Genotyp 1) mit Telaprevir-basierter Triple-Therapie : 30 Fragen - 30 Antworten

Therapie der chronischen Hepatitis C (Genotyp 1) mit Telaprevir-basierter Triple-Therapie : 30 Fragen - 30 Antworten

[Abstract] Hepatitis C Virus Subtypen in Patienten einer Frankfurter Klinik

[Abstract] Hepatitis C Virus Subtypen in Patienten einer Frankfurter Klinik

Perspectives and challenges of interferon-free therapy for chronic hepatitis C

Perspectives and challenges of interferon-free therapy for chronic hepatitis C

Viral hepatitis and its complications

Aufsatzsammlung

Viral hepatitis and its complications

Related objects